gsthr logo
Quick links to detailed datasheets for United States of America at gsthr.org

Smoking in United States of America

In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).

Read articles from United States of America

September 01, 2026 by realclearhealth.com

The FDA Is Making It Harder to Quit Smoking

A regulator can make quitting harder even while claiming to protect public health. Delayed approvals, narrow authorisation pathways and hostility towards safer nicotine products can leave adult smokers with fewer legal options than they need. Cigarettes remain widely available while alternatives that may help people switch face barriers that slow or block access. The FDA’s approach should be judged by whether it reduces smoking-related harm, not by how cautious it appears on paper.

August 28, 2026 by substack.com

JAMA Article on E-Cigarettes Makes Refreshingly Sound Recommendations to Clinicians

A JAMA article supporting clinician conversations about e-cigarettes should make the debate more precise. The evidence is strongest for adult smokers who use vaping as a route away from cigarettes, not for vague claims about nicotine use in general. That distinction matters because policy can either support full switching or bury it under uncertainty. Medical guidance should separate evidence from values clearly enough for smokers to understand their options.

August 27, 2026 by ocregister.com

Bureaucrats shouldn’t stand between smokers and safer choices

Smokers should not have to fight bureaucracy to reach safer choices. Regulation has a role in setting standards, preventing youth access and protecting consumers, but it should not become a barrier that leaves cigarettes as the easiest product to buy. Harm reduction depends on making lower-risk alternatives available, understandable and legally viable. Public health loses its purpose when process blocks the very options that could reduce harm.

August 27, 2026 by ocregister.com

Bureaucrats shouldn’t stand between smokers and safer choices

Smokers should not have to fight bureaucracy to reach safer choices. Regulation has a role in setting standards, preventing youth access and protecting consumers, but it should not become a barrier that leaves cigarettes as the easiest product to buy. Harm reduction depends on making lower-risk alternatives available, understandable and legally viable. Public health loses its purpose when process blocks the very options that could reduce harm.

August 25, 2026 by substack.com

A Flavor Is Not an Age Group

A flavour is not an age group, and regulation becomes weaker when it treats the two as the same. Adults who smoke often rely on flavoured products because taste can make switching away from cigarettes more acceptable and sustainable. Youth access should be prevented through age checks, retailer enforcement and penalties for illegal sales, not by removing options from adults. Public health needs precision: protect young people without making harm reduction less workable for smokers.

August 24, 2026 by regulatorwatch.com

Major Win | Court Ruling Could Dismantle FDA’s Flavored Vape Ban | RegWatch

The court ruling against the FDA’s approach to flavoured vapes could mark an important turning point for evidence-based regulation. Flavours are not a minor detail for many adults who switch from smoking; they can affect whether lower-risk products are acceptable enough to replace cigarettes. Youth protection remains essential, but it should be pursued through enforcement and product standards rather than blanket hostility to adult choice. A credible regulatory system should assess risk, behaviour and public health impact instead of treating flavour as automatic failure.

August 24, 2026 by goodgoodgood.co

Smoking rates reach historic low among youth in the United States

Historic-low youth smoking rates should be recognised as major public health progress. The latest US data also show falling youth vaping, challenging the idea that adult access to lower-risk nicotine products inevitably drives a youth crisis. Prevention still matters, especially for those who already vape frequently, but the message should be proportionate. Protecting young people and helping adult smokers leave cigarettes behind can be part of the same strategy.

August 20, 2026 by theconversation.com

US teens are smoking and vaping less than their peers abroad

Lower youth smoking and vaping rates in the US deserve attention because they challenge the assumption that harm reduction for adults must come at the cost of youth protection. The real question is what policies, norms and enforcement patterns are helping to reduce adolescent use while still recognising that adult smokers need alternatives to cigarettes. Youth prevention and adult harm reduction should not be treated as opposing goals. A serious nicotine strategy has to protect young people without distorting the risk message for everyone else.

August 19, 2026 by gfn.tv

Can Governments Enforce Their Way Out of the Illicit Market Crisis? | #GFN Voices 2026 #4

Enforcement cannot fix a market that policy itself is helping to create. Illicit nicotine trade grows where demand remains high, legal access is restricted and safer products are pushed outside accountable channels. Police action may disrupt supply, but it cannot remove the incentives that make illegal sales profitable. A serious response to the illicit market crisis has to combine enforcement with harm reduction, realistic regulation and legal options that adults will actually use.

August 18, 2026 by smokefreesweden.org

Doctor’s orders: Offer vapes to smokers as quitting tool

A JAMA publication should raise the standard of the nicotine debate, not narrow it into alarm. Research on smoking, vaping or smoke-free products needs to be read through the lens of comparison: what happens to people who continue smoking, switch completely, or use products alongside cigarettes. The public health value lies in that distinction. Evidence should clarify the movement away from combustion, not be used to make every nicotine product appear equally harmful.